Cargando…

The Effects of Antipsychotics in Experimental Models of Krabbe Disease

The role of altered myelin in the onset and development of schizophrenia and changes in myelin due to antipsychotics remains unclear. Antipsychotics are D(2) receptor antagonists, yet D(2) receptor agonists increase oligodendrocyte progenitor numbers and limit oligodendrocyte injury. Conflicting stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Kapil, Dev, Kumlesh K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215783/ https://www.ncbi.nlm.nih.gov/pubmed/37238985 http://dx.doi.org/10.3390/biomedicines11051313

Ejemplares similares

Fingolimod Rescues Demyelination in a Mouse Model of Krabbe's Disease
por: Béchet, Sibylle, et al.
Publicado: (2020)

Neuroimmune mechanisms in Krabbe's disease
por: Potter, Gregory B., et al.
Publicado: (2016)

Serendipitous effects of β-cyclodextrin on murine model of Krabbe disease
por: Katabuchi, Asaka U., et al.
Publicado: (2018)

Mechanotransduction Impairment in Primary Fibroblast Model of Krabbe Disease
por: Mezzena, Roberta, et al.
Publicado: (2023)

Advances in the Diagnosis and Treatment of Krabbe Disease
por: Wenger, David A, et al.
Publicado: (2021)

Krabbe disease: New hope for an old disease
por: Bradbury, Allison M., et al.
Publicado: (2021)

Gene therapy for CNS diseases – Krabbe disease
por: Rafi, Mohammad A.
Publicado: (2016)

Neurodegenerative Disorder Risk in Krabbe Disease Carriers
por: Vantaggiato, Lorenza, et al.
Publicado: (2022)

Chronic lithium administration in a mouse model for Krabbe disease
por: Del Grosso, Ambra, et al.
Publicado: (2021)

Globoid Cell Leukodystrophy (Krabbe Disease): An Update
por: Maghazachi, Azzam A
Publicado: (2023)

Azasugar inhibitors as pharmacological chaperones for Krabbe disease
por: Hill, Chris H., et al.
Publicado: (2015)

Krabbe disease: A personal perspective and hypothesis
por: Rafi, Mohammad A.
Publicado: (2022)

Quantification of 3D Brain Microangioarchitectures in an Animal Model of Krabbe Disease
por: Righi, Marco, et al.
Publicado: (2019)

Efficacy and Safety of a Krabbe Disease Gene Therapy
por: Hordeaux, Juliette, et al.
Publicado: (2022)

Targeting S1P receptors in experimental autoimmune encephalomyelitis in mice improves early deficits in locomotor activity and increases ultrasonic vocalisations
por: Sheridan, Graham K., et al.
Publicado: (2014)

Molecular Mechanisms of Disease Pathogenesis Differ in Krabbe Disease Variants
por: Spratley, Samantha J., et al.
Publicado: (2016)

Optic nerve enlargement in infantile form of Krabbe disease
por: Castilha-Neto, Dimas, et al.
Publicado: (2012)

Adult Krabbe Disease That Was Successfully Treated with Intravenous Immunoglobulin
por: Fukazawa, Ryosuke, et al.
Publicado: (2020)

National U.S. Patient and Transplant Data for Krabbe Disease
por: Ghabash, Gabrielle, et al.
Publicado: (2021)

Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
por: Cappello, Valentina, et al.
Publicado: (2016)

Brainstem development requires galactosylceramidase and is critical for pathogenesis in a model of Krabbe disease
por: Weinstock, Nadav I., et al.
Publicado: (2020)

Visual System Impairment in a Mouse Model of Krabbe Disease: The Twitcher Mouse
por: Tonazzini, Ilaria, et al.
Publicado: (2020)

Report of a Case that Expands the Phenotype of Infantile Krabbe Disease
por: Nashabat, Marwan, et al.
Publicado: (2019)

New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones
por: Spratley, Samantha J., et al.
Publicado: (2016)

Genotype and phenotype classification of 29 patients affected by Krabbe disease
por: Madsen, Anna M. H., et al.
Publicado: (2019)

Krabbe Disease Associated With Mitochondrial Dysfunction in a Chinese Family
por: Wu, Liwen, et al.
Publicado: (2021)

Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer’s Disease
por: Fagan, Steven G., et al.
Publicado: (2022)

Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease
por: Kwon, Jennifer M., et al.
Publicado: (2018)

HDAC-6 inhibition ameliorates the early neuropathology in a mouse model of Krabbe disease
por: Braz, Sandra O., et al.
Publicado: (2023)

Galactosylceramidase deficiency and pathological abnormalities in cerebral white matter of Krabbe disease
por: Iacono, Diego, et al.
Publicado: (2022)

Psychosine enhances the shedding of membrane microvesicles: Implications in demyelination in Krabbe’s disease
por: D’Auria, Ludovic, et al.
Publicado: (2017)

Newborn Screening for Krabbe Disease—Illinois Experience: Role of Psychosine in Diagnosis of the Disease
por: Basheeruddin, Khaja, et al.
Publicado: (2021)

Array CGH improves detection of mutations in the GALC gene associated with Krabbe disease
por: Tanner, Alice K, et al.
Publicado: (2012)

Untargeted Lipidomic Approach for Studying Different Nervous System Tissues of the Murine Model of Krabbe Disease
por: Alabed, Husam B. R., et al.
Publicado: (2023)

β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease
por: Belleri, Mirella, et al.
Publicado: (2019)

Characterization of adipose-derived stromal/stem cells from the twitcher mouse model of krabbe disease
por: Zhang, Xiujuan, et al.
Publicado: (2013)

Krabbe Disease: Report of a Rare Lipid Storage and Neurodegenerative Disorder
por: Pavuluri, Pratyusha, et al.
Publicado: (2017)

Predominant Corticospinal Tract Involvement in a Late Infant with Krabbe Disease
por: Yoshimura, Ayumi, et al.
Publicado: (2016)

Benefits of newborn screening and hematopoietic cell transplant in infantile Krabbe disease
por: Page, Kristin M., et al.
Publicado: (2022)

Prion-like α-synuclein pathology in the brain of infants with Krabbe disease
por: Hatton, Christopher, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gqtidnm3apblcf4jel6834vkvk